Projects per year
Personal profile
Expertise
- Bone marrow and peripheral blood stem cells: biology and therapeutical use
- Stem cell processing and banking
- Tumo-host interactions in blood cancer (multiple myeloma)
Fingerprint
Dive into the research topics where Ivan Van Riet is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
EUAR240: JANE2: Joint Action on Networks of Expertise on Cancer
Neyns, B. (CoI (Co-Promotor)), Rooman, I. (CoI (Co-Promotor)), Beernaert, K. (CoI (Co-Promotor)), Giron, P. (CoI (Co-Promotor)), De Ridder, M. (CoI (Co-Promotor)), De Becker, A. (CoI (Co-Promotor)), Van Riet, I. (CoI (Co-Promotor)), Hes, F. J. (CoI (Co-Promotor)), Rogiers, A. (CoI (Co-Promotor)), Houbracken, I. (CoI (Co-Promotor)) & Vanderkerken, K. (Administrative Promotor)
1/11/24 → 31/10/28
Project: Applied
-
ANI406: Liquid biopsies as non-invasive, patient-friendly tools for comprehensive (epi)genetic tumor characterization and disease follow-up in multiple myeloma
Van Riet, I. (Administrative Promotor) & Heestermans, R. (Collaborator)
3/10/24 → 30/09/26
Project: Fundamental
-
FWOTBM13: TBM Project: Ultra-sensitive minimal residual disease assessment by blood-based clonotypic mass spectrometry approach in plasma cell dyscrasias (MASSIAS)
Van Riet, I. (Administrative Promotor) & Bakkus, M. (CoI (Co-Promotor))
1/10/23 → 30/09/27
Project: Applied
-
ADSI279: Internal transfer for Mr. Song Xu and Kim De Veirman
Van Riet, I. (Administrative Promotor)
1/03/11 → …
Project: Fundamental
-
ANI52: Cycle for Life 2007 : Circulating endothelial cells in multiple myeloma: characterisation and study of their role as surrogate marker for myeloma-induced angiogenesis.
Vande Broek, I. (Co-Promotor) & Van Riet, I. (Administrative Promotor)
27/09/07 → …
Project: Fundamental
Research output
-
Blood-derived cell-free DNA is a superior biomarker for noninvasive DNA methylation profiling in multiple myeloma
Heestermans, R., Olsen, C., Ameli, S., Succari, J., Janssen, T., De Brouwer, W., De Becker, A., Vande Broek, I., Bakkus, M., Schots, R., De Bruyne, E. & Van Riet, I., 26 Aug 2025, In: Blood Advances. 9, 16, p. 4306-4310 5 p.Research output: Contribution to journal › Letter › peer-review
Open AccessFile3 Citations (Scopus)21 Downloads (Pure) -
Comparative Analysis of Bone Marrow, cfDNA and CTCs for NGS-Based Multiple Myeloma Detection: A Pilot Study Indicating the Potential of CTCs
De Brouwer, W., Heestermans, R., Van Der Straeten, J., Falise, K., De Becker, A., Vande Broek, I., Schots, R., Bakkus, M. H. C. & Van Riet, I., 16 Dec 2025, In: Cancers. 17, 24, 16 p., 4008.Research output: Contribution to journal › Article › peer-review
Open AccessFile2 Citations (Scopus)4 Downloads (Pure) -
Oncolytic HSV-1 expressing FLT3L kills melanoma, glioblastoma, and pancreatic cancer cells in vitro and induces immunogenic cell death.
Tuyaerts, S., Geeraerts, X., Reale, A., Stevens, L., Bertazzon, G., Brons, J., Janssen, T., Van Riet, I., Calistri, A. & Neyns, B., 18 Sept 2025, In: Molecular therapy. Oncology. 33, 3, 15 p., 201031.Research output: Contribution to journal › Article › peer-review
Open AccessFile1 Citation (Scopus)16 Downloads (Pure) -
A randomized phase II clinical trial of stereotactic body radiation therapy (SBRT) and systemic pembrolizumab with or without intratumoral avelumab/ipilimumab plus CD1c (BDCA-1)+/CD141 (BDCA-3)+ myeloid dendritic cells in solid tumors
Vounckx, M., Tijtgat, J., Stevens, L., Dirven, I., Ilsen, B., Vandenbroucke, F., Raeymaeckers, S., Vekens, K., Forsyth, R., Geeraerts, X., Van Riet, I., Schwarze, J. K., Tuyaerts, S., Decoster, L., De Ridder, M., Dufait, I. & Neyns, B., 2 Jul 2024, In: Cancer Immunol Immunother. 73, 9, 8 p., 167.Research output: Contribution to journal › Article › peer-review
Open AccessFile11 Citations (Scopus)71 Downloads (Pure) -
Comprehensive (Epi)Genetic Tumor Characterization and Disease Follow-Up in Multiple Myeloma Using Blood-Derived Cell-Free DNA
Heestermans, R., Olsen, C., Succari, J., Ameli, S., Janssen, T., De Becker, A., Vande Broek, I., Bakkus, M. H. C., Schots, R., De Bruyne, E. & Van Riet, I., 5 Nov 2024.Research output: Unpublished contribution to conference › Poster
Datasets
-
Tumor characterization and disease follow-up in multiple myeloma by genetic and epigenetic profiling using liquid biopsies
Van Riet, I. (Creator), Heestermans, R. (Creator), De Bruyne, E. (Creator), Schots, H. (Creator), Bakkus, M. (Creator), De Brouwer, W. (Creator), Olsen, C. (Creator), Janssen, T. (Creator), Caljon, B. (Creator), Succari, J. (Creator), Ameli, S. (Creator), De Becker, A. (Creator), Maes, K. (Creator), Vaeyens, F. (Creator) & Vande Broek, I. (Creator), VUB Institutional Data Repository, 10 Mar 2026
Dataset
Activities
-
Characterization of the evolving mutational landscape in multiple myeloma during disease progression using blood-derived cell free DNA: an explorative study
Heestermans, R. (Speaker), De Brouwer, W. (Contributor), Maes, K. (Contributor), Vande Broek, I. (Contributor), Vaeyens, F. (Contributor), Olsen, C. (Contributor), Janssen, T. (Contributor), De Becker, A. (Contributor), Bakkus, M. (Contributor), Schots, H. (Contributor) & Van Riet, I. (Contributor)
3 Feb 2023Activity: Talk or presentation › Talk or presentation at a conference
-
The best liquid biopsy for myeloma detection by immunoglobulin targeted NGS
De Brouwer, W. (Speaker), Van Riet, I. (Contributor), Heestermans, R. (Contributor), Van der Straeten, J. (Contributor), Vande Broek, I. (Contributor), Bakkus, M. (Contributor) & Schots, H. (Contributor)
4 Feb 2022Activity: Talk or presentation › Talk or presentation at a conference
-
Lab Secrets for Stratification and Prognoses of Leukemia and Multiple Myeloma using Next-Generation Sequencing (NGS): Strategies to Leverage NGS-based minimal residual disease (MRD) in Multiple Myeloma (MM) and Acute Lymphoblastic Leukemia (ALL)
De Brouwer, W. (Invited speaker), Van der Straeten, J. (Contributor), Van Riet, I. (Contributor) & Bakkus, M. (Contributor)
24 Feb 2022Activity: Talk or presentation › Talk at a public lecture/debate
-
29th General Annual Meeting of the Belgian Hematological Society
Van Riet, I. (Speaker)
30 Jan 2014 → 31 Jan 2014Activity: Talk or presentation › Talk or presentation at a workshop/seminar
-
28th General Annual Meeting of the Belgian Hematological Society
Van Riet, I. (Keynote speaker)
24 Jan 2013 → 26 Jan 2013Activity: Talk or presentation › Talk or presentation at a conference